E88.82
Obesity due to disruption of MC4R pathway
Clinical Classification Guidelines
Use Additional Code
- code, if applicable, to identify associated manifestations, such as polyphagia (R63.2)
Medical Intelligence & Overview
Obesity due to disruption of the MC4R pathway, classified under ICD-10 code E88.82, is a specific form of obesity caused by genetic or biochemical abnormalities affecting the melanocortin 4 receptor (MC4R). The MC4R plays a crucial role in regulating appetite and energy expenditure. When this pathway is disrupted, it leads to increased Hunger and decreased energy burn, resulting in excess body weight. Understanding the underlying causes, symptoms, and available options for management can help in identifying and addressing this condition effectively.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting the MC4R gene, leading to its dysfunction. Biochemical abnormalities interfering with the normal signaling of the MC4R pathway. Inherited genetic syndromes that disrupt the pathway responsible for appetite control. Rare cases where environmental factors may interact with genetic predisposition to impact MC4R functioning.
Key Symptoms: Early-onset obesity, often before the age of five. Excessive hunger and an insatiable appetite. Rapid weight gain and difficulty in losing weight despite dieting. Potential development of associated health issues like type 2 diabetes, hypertension, and sleep apnea. Possible behavioral or neurodevelopmental features in some genetic syndromes linked to MC4R mutations.
Diagnostic & Treatment
Diagnosis Path: Review the patient's medical history, focusing on early-onset obesity and family history. Conduct a physical examination and assess the severity of obesity and related health conditions. Order genetic testing to identify mutations in the MC4R gene. Perform metabolic and hormonal assessments to exclude other metabolic disorders. Utilize imaging or additional diagnostic tools if needed to evaluate associated health complications.
Treatment Protocols: Lifestyle modifications focused on nutrition and physical activity tailored to the individual's needs. Behavioral therapy to help manage appetite and develop healthy habits. Pharmacological options, such as medications that influence appetite regulation, though options may be limited. In some cases, surgical interventions like bariatric surgery might be considered, depending on the patient's overall health and severity. Support from a multidisciplinary team including dietitians, endocrinologists, and mental health professionals.
Clinical Advice & FAQs
Billing Guidance
Is E88.82 a billable ICD-10 code?
Yes, E88.82 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E88.82?
Clinical documentation must specify the nature of Obesity due to disruption of MC4R pathway and any associated comorbidities for accurate reporting.
Cite this Clinical Reference